Oezer, Kuebra http://orcid.org/0000-0002-7715-9816
Kolibabka, Matthias
Gassenhuber, Johann
Dietrich, Nadine
Fleming, Thomas
Schlotterer, Andrea
Morcos, Michael
Wohlfart, Paulus
Hammes, Hans-Peter
Funding for this research was provided by:
GRK 1874/2 DIAMICOM
SFB 1118
Sanofi-Aventis Deutschland
European Foundation for the Study of Diabetes
NIH Office of Research Infrastructure Programs
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 27 January 2023
Accepted: 10 June 2023
First Online: 9 July 2023
Declarations
:
: The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Gassenhuber and Paulus Wohlfart are a full-time employee of Sanofi Aventis Deutschland GmbH. All experiments and communication were performed within the IRTG GRK 1874 DIAMICOM reviewed by the Deutsche Forschungs Gemeinschaft, DFG. Sanofi Aventis had no influence on the interpretation nor the decision to publish these data.
: The animal study protocol was approved by the Institutional Review Board of Regierungspräsidium Karlsruhe (protocol code “Aktenzeichen: 35-9185.81/G-15/15” and date of approval 16.07.2015).
: Not applicable.